Medical equipment maker Bruker misses Q2 estimates, cuts forecast on academic market pressure
Overview
Bruker Q2 2025 revenue falls 0.4% yoy, missing analyst expectations
Non-GAAP diluted EPS drops 38.5% yoy, missing estimates, per LSEG data
Co announces cost savings initiative to reduce annual costs by $100-120 mln in FY 2026
Outlook
Bruker expects FY 2025 revenue of $3.43 to $3.50 bln
Company anticipates FY 2025 non-GAAP EPS of $1.95 to $2.05
Bruker sees organic revenue decline of 2% to 4% in FY 2025
Company cites US academic market pressure affecting FY 2025 outlook
Result Drivers
DEMAND PRESSURE - Life-science research instruments demand under pressure, particularly in US academic and biopharma markets, per CEO Frank H. Laukien
CURRENCY HEADWINDS - Tariffs and currency headwinds impacted results, despite mitigating actions
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $797.40 mln | $811.40 mln (11 Analysts) |
Q2 Adjusted EPS | Miss | $0.32 | $0.42 (12 Analysts) |
Q2 Net Income |
| $4.20 mln |
|
Q2 Gross Profit |
| $357.90 mln |
|
Q2 Operating Expenses |
| $346 mln |
|
Q2 Operating Income |
| $11.90 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Bruker Corp is $47.50, about 20% above its August 1 closing price of $37.99
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago
Press Release: ID:nBw2PWc6Ba
Related Articles
[Crypto IPO] Figure Skyrockets 44% on IPO Debut, All Eyes Now on Gemini as the Next Crypto Star
Figure’s strong first-day performance sets the stage for Gemini’s highly anticipated listing.
[Reuters Breakingviews] Inflation defences are no match for debt burden
By Edward ChancellorLONDON, Sept 11 (Reuters Breakingviews) - Countries across the Western world are over-indebted. In theory, they could grow their way out of the debt or rein in their fiscal deficits. But the richer countries have a miserable recent growth record. And as the fall of French Prime M
U.S. August CPI Preview: Persistent Rise in Inflation, What Impact on Rate Cuts? And on US Stocks?
TradingKey - On 11 September 2025, the U.S. will publish August CPI data. Consensus forecasts indicate a 0.3% month-over-month increase for both headline CPI and core CPI. As a result, headline CPI year-over-year may climb to 2.9%, up from 2.7%
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks ahead
